TNSN98083A1 - 6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Google Patents

6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Info

Publication number
TNSN98083A1
TNSN98083A1 TNTNSN98083A TNSN98083A TNSN98083A1 TN SN98083 A1 TNSN98083 A1 TN SN98083A1 TN TNSN98083 A TNTNSN98083 A TN TNSN98083A TN SN98083 A TNSN98083 A TN SN98083A TN SN98083 A1 TNSN98083 A1 TN SN98083A1
Authority
TN
Tunisia
Prior art keywords
preparation
pharmaceutical compositions
compounds
compositions containing
methylerythromycin
Prior art date
Application number
TNTNSN98083A
Other languages
French (fr)
Inventor
We Yong-Jin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98083A1 publication Critical patent/TNSN98083A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L’INVENTION CONCERNE DES COMPOSES DE FORMULE I DANS LAQUELLE R1, R2, R6 ET X REPRESENTENT DIVERS RADICAUX ORGANIQUES ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES. ELLE CONCERNE EGALEMENT DES COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES ET DES PROCEDES POUR LA PREPARATION DE CES COMPOSES. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS DANS LE TRAITEMENT D'INFECTIONS BACTERIENNES ET D'INFECTIONS PAR DES PROTOZOAIRES.THE INVENTION CONCERNS COMPOUNDS OF FORMULA I IN WHICH R1, R2, R6 AND X REPRESENT VARIOUS ORGANIC RADICALS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS. IT ALSO CONCERNS PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS FOR THE PREPARATION OF SUCH COMPOUNDS. APPLICATION: USE OF THESE COMPOUNDS AND COMPOSITIONS IN THE TREATMENT OF BACTERIAL INFECTIONS AND PROTOZOA INFECTIONS.

TNTNSN98083A 1997-06-11 1998-06-10 6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. TNSN98083A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
TNSN98083A1 true TNSN98083A1 (en) 2005-03-15

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98083A TNSN98083A1 (en) 1997-06-11 1998-06-10 6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
ES2243066T3 (en) 1998-09-22 2005-11-16 Pfizer Products Inc. CARBAMATE AND CETOLID CARBAZATE ANTIBIOTICS.
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
SK15162001A3 (en) 1999-05-24 2003-02-04 Pfizer Products Inc. 13-Methyl-erythromycin derivatives
PT1181300E (en) * 1999-06-07 2004-02-27 Abbott Lab DERIVATIVES 6-O-CARBAMATE OF CETOLID
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
JP5698979B2 (en) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド Process for preparing macrolide antibacterial agents
JP5602748B2 (en) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ,インコーポレイテッド Bioprotection using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (en) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedures for the treatment of malaria, tuberculosis and MAC diseases
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
BR112012029586A2 (en) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processes for preparing macrolides and ketolides and intermediates thereof
JP6042334B2 (en) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド Hydrogen bond forming fluoroketolides for disease treatment
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP6426696B2 (en) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド Methods and formulations for the treatment of respiratory diseases
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
HRP980316A2 (en) 1999-04-30
AR012244A1 (en) 2000-09-27
BR9810021A (en) 2000-09-19
EA199901016A1 (en) 2000-06-26
TW448174B (en) 2001-08-01
OA11225A (en) 2003-07-17
IL132767A0 (en) 2001-03-19
CA2293335A1 (en) 1998-12-17
TR199902995T2 (en) 2000-02-21
BG103947A (en) 2000-07-31
HUP0002252A2 (en) 2000-12-28
EP0988308A1 (en) 2000-03-29
PL337606A1 (en) 2000-08-28
AP9801253A0 (en) 1999-12-04
IS5251A (en) 1999-11-16
CO4940506A1 (en) 2000-07-24
CZ9904388A3 (en) 2002-10-16
WO1998056800A1 (en) 1998-12-17
HUP0002252A3 (en) 2002-01-28
AU7226798A (en) 1998-12-30
GT199800074A (en) 1999-11-27
PE79899A1 (en) 1999-08-25
PA8451801A1 (en) 2000-05-24
HN1998000073A (en) 1999-01-08
ZA985018B (en) 1999-12-10
KR20010013660A (en) 2001-02-26
CN1259135A (en) 2000-07-05
MA26505A1 (en) 2004-12-20
ID24529A (en) 2000-07-20
JP2000513026A (en) 2000-10-03
NO996108D0 (en) 1999-12-10
NO996108L (en) 2000-02-10

Similar Documents

Publication Publication Date Title
TNSN98083A1 (en) 6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98203A1 (en) THIENOPYRIMIDINE AND TIENOPYRIDINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS, AND COMPOSITIONS CONTAINING THEM
TNSN98082A1 (en) SUBSTITUTED DERIVATIVES IN C - 4 OF 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCIN A.
TNSN99162A1 (en) NEW ALCYNYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97110A1 (en) DERIVATIVES OF 2- (2-OXO-ETHYLIDENE) -IMIDAZOLIDINE-4-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99169A1 (en) NOVEL 4,4-BIARYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99236A1 (en) NOVEL SUBSTITUTED BICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN96172A1 (en) HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98194A1 (en) NOVEL 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN00104A1 (en) NOVEL ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98084A1 (en) DERIVATIVES OF SUBSTITUTED MACROLIDES IN POSITION C-4
TNSN99214A1 (en) NOVEL AZALIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN00028A1 (en) NEW HETEROARYL SUBSTITUTE QUINOLEIN -2-ONE DERIVATIVES NEW PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98237A1 (en) AZAPOLYCYCLIC COMPOUNDS WITH CONDENSED ARYL CORE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99171A1 (en) 4-CARBOXYAMINO-2-SUBSTITUE-1,2,3,4-TETRAHYDROQUINOLEINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97087A1 (en) NOVEL 4 (3H) -QUINAZOLINONES 2,3-DISUBSTITUTED, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97192A1 (en) CONDENSED BICYCLIC PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98238A1 (en) NEW MACROLIDES
TNSN00065A1 (en) NOVEL PYRIMIDINE DERIVATIVES OF SORBITOL-DEHYDROGENASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98150A1 (en) DERIVATIVES OF ARYLOXYARYLSULFONYLAMINOHYDROXAMIC ACIDS; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99126A1 (en) NOVEL PYRROLOPYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99170A1 (en) NOVEL SUBSTITUTED TETRAHYDROQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99125A1 (en) NEW PYRROLO (2,3-D) PYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99155A1 (en) 1-ARYL-3-ARYLMETHYL-1,8-NAPHTYRIDINE-4 (1H) -ONES NOVELS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97044A1 (en) QUINOXALINEDONE DERIVATIVES, METHODS AND INTERMEDIATES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.